logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > ARS-1620 CAS 1698055-85-4 API Active Pharmaceutical Ingredient

ARS-1620 CAS 1698055-85-4 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1698055-85-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

ARS-1620 CAS 1698055-85-4

,

CAS 1698055-85-4 ARS-1620

CAS NO::
1698055-85-4
Appearance::
Off-white To White Solid
Molecular Formula::
C21H17ClF2N4O2
Molecular Weight::
430.83500
EINECS NO::
NA
MDL NO::
NA
CAS NO::
1698055-85-4
Appearance::
Off-white To White Solid
Molecular Formula::
C21H17ClF2N4O2
Molecular Weight::
430.83500
EINECS NO::
NA
MDL NO::
NA
ARS-1620 CAS 1698055-85-4 API Active Pharmaceutical Ingredient

Product Description:

Product Name: ARS-1620 CAS NO: 1698055-85-4

 

 

Synonyms:

(R)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one;

2-Propen-1-one,1-[4-[(7S)-6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-quinazolinyl]-1-piperazinyl]-;

 

 

Chemical & Physical Properties:

Appearance: Off-white to white solid

Assay :≥98.0%

Boiling Point: 614.7±55.0℃(Predicted)

Density: 1.434±0.06 g/cm3 (Predicted)

PKa: 6.03±0.35 (Predicted)

 

 

ARS-1620 is a potent and orally active covalent inhibitor of KrasG12c, which produces rapid and sustained binding (seizure) of targets in vivo and induces tumor regression. ARS-1620 is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics. ARS-1620 is a potent, selective, and orally bioavailable covalent KRAS-G12C inhibitor. ARS-1620 inhibits KRAS with high potency in cells and animals. Moreover, ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.